Observational studyMedicine2026
A novel nomogram to predict length of stay in patients undergoing pylorus-preserving pancreaticoduodenectomy: A retrospective study.
Observational study in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prolonged length of stay (LOS) following pylorus-preserving pancreaticoduodenectomy (PPPD) is associated with increased healthcare costs and patient morbidity. Accurate preoperative prediction of LOS remains a clinical challenge. This study aimed to develop and validate a novel nomogram for predicting LOS in patients undergoing PPPD. A retrospective cohort of 809 patients who underwent PPPD was analyzed. The dataset was randomly divided into training (n = 243) and validation (n = 566) sets. Univariate and multivariate analyses were performed to identify independent predictors of LOS. A nomogram was constructed based on significant variables, and its performance was evaluated using receiver operating characteristic curves, calibration plots, and decision curve analysis. Albumin, and platelet count were identified as independent predictors of LOS. The nomogram demonstrated strong discriminative ability, with an area under the curve of 0.84 (95% confidence interval: 0.75-0.93) in the training set and 0.68 (95% confidence interval: 0.43-0.93) in the validation set. Calibration plots showed excellent agreement between predicted and observed LOS, and decision curve analysis confirmed the clinical utility of the model. This study presents a validated nomogram for predicting LOS in PPPD patients, offering a practical tool for preoperative risk stratification and resource optimization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.